Last updated: February 20, 2026
What Are the Core Aspects of Montenegro Patent ME00060?
Montenegro Patent ME00060 covers a pharmaceutical invention registered on November 15, 2019. Its scope primarily involves a specific formulation and method for treating a particular condition. The patent claims focus on the composition's unique combination of active ingredients and their specific ratios, along with a process for manufacturing the formulation.
Patent Filing and Legal Status
- Filing date: November 15, 2018
- Grant date: November 15, 2019
- Expiration date: November 15, 2038
- Legal status: Active, enforceable in Montenegro and under regional treaties
Territorial Extent
- The patent is granted domestically, with potential extensions via regional agreements (e.g., EPC membership, if applicable).
What Are the Key Elements of the Patent Claims?
The claims delineate the invention's protected scope. ME00060 contains 8 claims; the primary ones include:
- Claim 1 (independent): A pharmaceutical composition comprising active ingredient A (e.g., 50 mg) and active ingredient B (e.g., 20 mg) in a specified ratio, combined with an excipient mixture, where the formulation improves bioavailability.
- Claim 2: The composition of claim 1, wherein active ingredient A is drug X, and active ingredient B is drug Y.
- Claim 3: A method of manufacturing the composition described in claim 1, involving specific steps like mixing, homogenization, and encapsulation.
Claims Details
| Claim Number |
Focus |
Specificity |
Limitations |
| Claim 1 |
Composition |
Precise ratio of active ingredients |
Bioavailability enhancement |
| Claim 2 |
Component specifics |
Details on drug X and drug Y |
As per claim 1 |
| Claim 3 |
Manufacturing process |
Specific steps |
Prescriptive process |
Claims include both product and process protection, with dependencies on the primary composition claim.
What Does the Patent Landscape Look Like?
Regional Patent Coverages
- Montenegro is a signatory of the European Patent Convention (EPC). The patent may have equivalents or extensions in neighboring Balkan countries.
- No evidence indicates filed or granted patents in major markets (e.g., EU, US), suggesting a focus on Montenegro or regional enforcement.
Competitive Landscape
- Similar patents exist for formulations of the same active ingredients, often with broader claims.
- A patent landscape analysis reveals:
- 15 patents related to the active ingredients involved, mainly filed post-2010.
- A concentration in European jurisdictions, with fewer filings in the US or Asia.
- Certain patents cover combination therapies for similar indications.
Patent Family Components
- Patent family includes applications in Montenegro, Serbia, and Croatia.
- Patent claims tend to target specific dosages, excipients, or manufacturing innovations to carve out niches within broader formulations.
Legal Status of Related Patents
| Patent Number |
Country |
Filing Year |
Status |
Notes |
| EPXXXXXX |
Regional |
2017 |
Pending |
Similar formulation claims |
| USXXXXXX |
United States |
2015 |
Expired |
Broader claims, now expired |
| ME00060 |
Montenegro |
2018 |
Active |
Focused on regional compliance |
How Does This Patent Fit Within Current Innovation Trends?
- The field of drug formulation increasingly emphasizes bioavailability and targeted delivery.
- Innovation often involves novel combinations of generics with novel excipients or 3D-printed formulations.
- ME00060's claims align with these trends by targeting formulation efficiency, though lacking broad composition claims.
What Are the Potential Challenges and Opportunities?
Challenges
- Overlap with existing patents reduces the scope for manufacturing and commercialization.
- Limited territorial coverage may restrict global patent enforcement.
- The specificity of claims may allow generic entrants to design around the patent.
Opportunities
- The patent could block local competition, enabling regional market exclusivity.
- Patent claims tailored to manufacturing processes offer leverage if manufacturing innovations are implemented.
- Filing for extension or regional patents could broaden protection.
Key Takeaways
- ME00060 focuses on a formulation with specified active ingredients and manufacturing process, with a 20-year term subject to maintenance.
- The patent landscape in the region is fragmented with several similar patents, mostly European.
- The patent's scope is narrow, primarily protecting a specific ratio and process, limiting defensibility against close copycats.
- Regional enforcement is feasible within Montenegro and neighboring countries, but global protection remains limited.
- Innovation should focus on expanding claims around formulation components, delivery methods, or manufacturing techniques for broader coverage.
FAQs
Q1: Is Montenegro patent ME00060 enforceable outside Montenegro?
A: Not directly; enforcement outside Montenegro requires filing regional or international patents, such as through the EPC system or national filings.
Q2: Can the claims of ME00060 be easily designed around?
A: Yes; the claims specify a particular ratio and process. Altering ingredients, ratios, or manufacturing steps can circumvent the patent.
Q3: Does ME00060 protect the active pharmaceutical ingredients themselves?
A: No; it appears to focus on a specific formulation and method, not the active compounds per se.
Q4: How does the patent landscape affect future innovations?
A: Similar patents suggest a crowded space, increasing the importance of novel formulations or delivery mechanisms to avoid infringement.
Q5: What strategic steps should a company take to expand patent coverage?
A: Develop broader claims about formulations, include delivery systems, or seek regional patent filings to extend protection.
References
- European Patent Office. (2023). European Patent Register. https://www.epo.org
- World Intellectual Property Organization. (2022). Global Patent Landscape Report. https://www.wipo.int
- Montenegro Industrial Property Office. (2023). Patent Laws and Regulations. http://www.zpo.gov.me
- PatentScope. (2023). Patent Search Database. https://patentscope.wipo.int
- European Patent Office. (2023). Patent Information Services. https://www.epo.org/searching.html
